These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Limited significance of asymmetric adrenal visualization on dexamethasone-suppression scintigraphy. Gross MD; Shapiro B; Freitas JE J Nucl Med; 1985 Jan; 26(1):43-8. PubMed ID: 2981301 [TBL] [Abstract][Full Text] [Related]
23. [Computer tomographic localisation in primary aldosteronism. Comparison with adrenal scintigraphy (author's transl)]. Galanski M; Fischer M; Cramer BM; Friemann J; Vetter H Rofo; 1980 Dec; 133(6):629-33. PubMed ID: 6453793 [TBL] [Abstract][Full Text] [Related]
24. The detection of adrenal tumors and hyperplasia in patients with primary aldosteronism: comparison of scintigraphy, CT, and MR imaging. Ikeda DM; Francis IR; Glazer GM; Amendola MA; Gross MD; Aisen AM AJR Am J Roentgenol; 1989 Aug; 153(2):301-6. PubMed ID: 2665450 [TBL] [Abstract][Full Text] [Related]
27. Bilateral adrenal tumours in primary aldosteronism: localization of a unilateral aldosteronoma by dexamethasone suppression scan. Hollak CE; Prummel MF; Tiel-van Buul MM J Intern Med; 1991 Jun; 229(6):545-8. PubMed ID: 2045765 [TBL] [Abstract][Full Text] [Related]
28. The relationship of serum lipids to adrenal-gland uptake of 6 beta-[131I]iodomethyl-19-norcholesterol in Cushing's syndrome. Valk TW; Gross MD; Freitas JE; Swanson DP; Schteingart DE; Beierwaltes WH J Nucl Med; 1980 Nov; 21(11):1069-72. PubMed ID: 7431105 [TBL] [Abstract][Full Text] [Related]
29. [Nuclear medicine diagnostic localization in primary aldosteronism and Cushing syndrome]. Sialer G; Marincek B; Mengden T; Vetter W Bildgebung; 1987-1989; 56(4):157-62. PubMed ID: 3078253 [TBL] [Abstract][Full Text] [Related]
30. Iodomethylnorcholesterol uptake in an aldosteronoma shown by dexamethasone-suppression scintigraphy: relationship to adenoma size and functional activity. Nomura K; Kusakabe K; Maki M; Ito Y; Aiba M; Demura H J Clin Endocrinol Metab; 1990 Oct; 71(4):825-30. PubMed ID: 2401712 [TBL] [Abstract][Full Text] [Related]
31. A new and superior adrenal imaging agent, 131I-6beta-iodomethyl-19-nor-cholesterol (NP-59): evaluation in humans. Sarkar SD; Cohen EL; Beierwaltes WH; Ice RD; Cooper R; Gold EN J Clin Endocrinol Metab; 1977 Aug; 45(2):353-62. PubMed ID: 885997 [TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of adrenal iodine-131 6-beta-iodomethyl-19-norcholesterol scintigraphy for primary aldosteronism: a retrospective study at a medical center in North Taiwan. Wu MH; Liu FH; Lin KJ; Sun JH; Chen ST Nucl Med Commun; 2019 Jun; 40(6):568-575. PubMed ID: 30694876 [TBL] [Abstract][Full Text] [Related]
34. 131I-6β-iodomethyl-19-norcholesterol adrenal scintigraphy as an alternative to adrenal venous sampling in differentiating aldosterone-producing adenoma from bilateral idiopathic hyperaldosteronism. Saiga A; Yokota H; Nagano H; Sawada K; Kubota Y; Wada T; Horikoshi T; Tanaka T; Uno T Nucl Med Commun; 2020 Dec; 41(12):1226-1233. PubMed ID: 32956247 [TBL] [Abstract][Full Text] [Related]
35. Interference by spironolactone on adrenocortical scintigraphy and other pitfalls in the location of adrenal abnormalities in primary aldosteronism. Shapiro B; Grekin R; Gross MD; Freitas JE Clin Nucl Med; 1994 May; 19(5):441-5. PubMed ID: 8039321 [TBL] [Abstract][Full Text] [Related]
36. Is there a role for Nuclear Medicine in diagnosis and management of patients with primary aldosteronism? Spyridonidis TJ; Apostolopoulos DJ Hell J Nucl Med; 2013; 16(2):134-9. PubMed ID: 23865085 [TBL] [Abstract][Full Text] [Related]
37. A new adrenal computer imaging technique using dual-radioisotopes. Ohashi T; Morioka M; Mitsuhata N; Akaeda T; Ohmori H Acta Med Okayama; 1981 Jun; 35(3):165-72. PubMed ID: 6457507 [TBL] [Abstract][Full Text] [Related]
38. Imaging of an adrenal cortical carcinoma and its skeletal metastasis. Drane WE; Graham MM; Nelp WB J Nucl Med; 1983 Aug; 24(8):710-2. PubMed ID: 6875680 [TBL] [Abstract][Full Text] [Related]
39. Failure to visualize bilateral adrenal glands in a patient with primary aldosteronism. Seino M; Abe K; Imai Y; Murakami O; Kasai Y; Sasaki S; Minami N; Munakata M; Kanazawa M; Takeuchi K Clin Exp Hypertens A; 1990; 12(1):37-46. PubMed ID: 2155075 [TBL] [Abstract][Full Text] [Related]